Mitsui Chemicals (4183) AI Stock Analysis

• Market Cap: ¥707.11B
• Dividend Yield: 4.02%
• Average Volume (3M): 1.23M
• Price to Earnings (P/E): 46.8
• Beta (1Y): 1.16
• Revenue Growth: -0.91%
• EPS Growth: -74.07%
• Country: JP
• Employees: 19,861
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 3.89
• Shares Outstanding: 200,843,810
• 10 Day Avg. Volume: 861,960
• 30 Day Avg. Volume: 1,229,390
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,689.77
• Price Target Upside: 25.70% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 67 Neutral
• Price Target: ¥3,970.00 ▲(6.41% Upside)

Mitsui Chemicals' stock score is primarily driven by its stable financial management and positive technical indicators. However, the high P/E ratio suggests potential overvaluation, which is a significant risk factor. The strong cash flow and attractive dividend yield provide some support, but declining profitability and negative revenue growth remain concerns.

Mitsui Chemicals Business Overview & Revenue Model

Company Description

Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Mitsui Chemicals generates revenue through the manufacture and sale of a wide range of chemical products and materials. The company's key revenue streams include petrochemicals, where it produces basic chemicals and raw materials used in the production of plastics and synthetic rubbers, and performance materials, which encompass high-performance polymers and resins used in automotive and packaging industries. Additionally, its functional materials division focuses on healthcare and electronic materials, offering products such as dental materials, agrochemicals, and semiconductor materials. Mitsui Chemicals also benefits from strategic partnerships and joint ventures that enhance its market reach and technological capabilities, contributing significantly to its earnings.

Mitsui Chemicals Financial Statement Overview

Summary

Mitsui Chemicals demonstrates stable financial management with consistent gross margins and a solid balance sheet. However, declining profitability and negative revenue growth indicate challenges in market expansion and operational efficiency. Cash flow generation is strong, providing a buffer against profitability pressures.

Income Statement

Mitsui Chemicals shows a stable gross profit margin around 21%, indicating consistent cost management. However, the net profit margin has decreased to 1.78% in the TTM, reflecting reduced profitability. Revenue growth is negative at -1.89% in the TTM, suggesting challenges in expanding sales. The EBIT and EBITDA margins have also declined, indicating pressure on operational efficiency.

Balance Sheet

The company's debt-to-equity ratio is stable at approximately 0.87, indicating moderate leverage. Return on equity has decreased to 3.72% in the TTM, showing reduced profitability for shareholders. The equity ratio remains healthy, suggesting a solid capital structure.

Cash Flow

Operating cash flow has improved, with a positive free cash flow growth rate of 12.86% in the TTM. The operating cash flow to net income ratio is strong, indicating good cash generation relative to earnings. However, the free cash flow to net income ratio is moderate, suggesting room for improvement in cash flow efficiency.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.78T	1.81T	1.75T	1.88T	1.61T	1.21T
Gross Profit	382.25B	388.29B	370.80B	381.49B	378.74B	293.84B
EBITDA	153.46B	186.12B	183.24B	197.27B	204.58B	150.44B
Net Income	15.08B	32.24B	50.00B	82.94B	109.99B	57.87B
Balance Sheet
Total Assets	2.11T	2.15T	2.22T	2.07T	1.93T	1.56T
Cash, Cash Equivalents and Short-Term Investments	180.51B	209.23B	210.29B	186.31B	181.15B	195.99B
Total Debt	749.27B	737.98B	756.76B	738.25B	666.09B	510.22B
Total Liabilities	1.15T	1.18T	1.23T	1.18T	1.13T	875.97B
Stockholders Equity	829.90B	848.28B	862.85B	786.83B	712.65B	607.92B
Cash Flow
Free Cash Flow	89.48B	62.09B	7.35B	-36.62B	-23.63B	97.74B
Operating Cash Flow	206.13B	200.50B	161.34B	101.24B	92.58B	174.32B
Investing Cash Flow	-165.79B	-165.01B	-123.94B	-106.34B	-205.23B	-77.56B
Financing Cash Flow	-72.13B	-74.44B	-26.02B	2.54B	89.22B	-68.96B

Mitsui Chemicals Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3731.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4183, the sentiment is Positive. The current price of 3731 is above the 20-day moving average (MA) of 3729.45, above the 50-day MA of 3567.34, and above the 200-day MA of 3331.98, indicating a bullish trend. The MACD of 55.05 indicates Positive momentum. The RSI at 55.64 is Neutral, neither overbought nor oversold. The STOCH value of 22.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4183.

Mitsui Chemicals Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4202	81 Outperform	371.33B	8.82	13.75%	4.06%	1.29%	-22.20%
4118	74 Outperform	276.04B	12.19	5.36%	3.00%	3.80%	-11.14%
4182	71 Outperform	532.51B	12.86	6.82%	3.36%	-6.27%	40.98%
4403	68 Neutral	630.61B	18.48	13.10%	1.68%	4.89%	-3.79%
4183	67 Neutral	¥707.11B	46.77	1.78%	4.02%	-0.91%	-74.07%
5201	64 Neutral	1.01T	29.30	2.49%	4.40%	-0.06%	0.00%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Mitsui Chemicals Corporate Events

Mitsui Chemicals Faces Revenue Decline in Q1 FY2025 Amid Market Challenges

Mitsui Chemicals reported a decline in sales revenue and operating income for the first quarter of FY2025 compared to the previous year, with notable decreases in the Basic & Green Materials segment. Despite the organizational reforms and segment revisions, the company faces challenges in maintaining profitability amidst fluctuating exchange rates and naphtha prices, impacting its financial performance and market positioning.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Completes Treasury Shares Disposal for Compensation

Mitsui Chemicals has completed the payment procedures for the disposal of 29,900 treasury shares as restricted stock-based compensation, a decision made by its Board of Directors in June 2025. This move is part of the company’s compensation strategy, potentially impacting its financial structure and aligning the interests of its executives with company performance.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Announces Disposal of Treasury Shares for Stock-Based Compensation

Mitsui Chemicals has announced the disposal of 29,900 treasury shares as part of a restricted stock-based compensation plan aimed at enhancing corporate value. This plan is designed to align the interests of the company’s directors and executive officers with those of its shareholders, thereby promoting sustainable growth and retaining skilled personnel.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Transfers Equity in Shanghai Joint Venture to Sinopec

Mitsui Chemicals has announced its decision to transfer its equity interest in Shanghai Sinopec Mitsui Chemicals to Sinopec Shanghai Gaoqiao Petrochemical. This move is part of Mitsui’s strategy to optimize its phenols business amidst a challenging business environment, characterized by declining demand in Japan and increased overseas competition. The transfer is expected to help Mitsui focus on restructuring and enhancing its derivatives’ performance, aligning with its broader goal of minimizing revenue volatility and strengthening its green chemicals business.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Plans Strategic Split to Boost Green Initiatives

Mitsui Chemicals is considering splitting off its Basic & Green Materials business to enhance its business structure and promote green initiatives. This strategic move aims to foster collaboration with other companies, improve competitiveness, and support Japan’s industrial competitiveness by creating a strong, independent green chemicals business entity by 2027.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports Decline in FY2024 Financial Results

Mitsui Chemicals announced a decline in its FY2024 non-consolidated financial results compared to the previous fiscal year. The company reported a decrease in ordinary and net income, primarily due to reduced operating income and dividend income, impacting its financial performance and potentially affecting stakeholder confidence.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports FY2024 Financial Shortfall

Mitsui Chemicals reported a shortfall in its FY2024 financial results compared to its previous forecasts. The decline was primarily due to decreased sales in the ICT Solutions segment and an impairment loss in the Life & Healthcare Solutions segment, along with increased income tax expenses. Despite these challenges, the company maintained its dividend forecast.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports 5% Increase in FY2024 Operating Income

Mitsui Chemicals reported a 5% increase in operating income before special items for FY2024, reaching 101.0 billion yen, driven by growth in specialty chemicals and successful sales price revisions in basic materials. Despite challenges such as an ethylene plant failure in Osaka, the company managed to offset losses through strategic business restructuring, indicating a strong market position and resilience.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports FY2024 Financial Results with Mixed Performance

Mitsui Chemicals reported its consolidated financial results for FY2024, showing a slight increase in sales revenue and operating income. Despite challenges in certain segments, the company saw growth in Life & Healthcare Solutions and Mobility Solutions. The organizational reforms and segment revisions implemented in April 2024 are expected to impact future performance positively. However, the company faced a decrease in net income and cash flow challenges, indicating a need for strategic adjustments to maintain financial stability.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.